CD274 and non-small cell lung carcinoma: Increasing evidence links the gut microbiome to ICI activity, but the predictive value of the salivary microbiome is poorly defined.<h4>Methods</h4>We prospectively analyzed baseline saliva from 71 stage IV NSCLC patients treated with anti-PD-1/PD-L1 (ICI) monotherapy.